Evidence map›Paper›PMID 41310537›Full record

ArticleBMC psychiatry2025

Impact of somatic comorbidities on healthcare costs in patients with severe mental disorders: a cross-sectional study in Beijing.

Qingzhi Huang, Yu Xin, Junli Zhu, Yao Dong, Yun Chen, Chen Chen, Wei Lu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Qingzhi Huang *Beijing Key Laboratory of Mental Disorders, National Clinical Research Center for Mental Disorders & National Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, People's Republic of China.
Yu Xin *School of Public Health, Capital Medical University & Research Center for Capital Health Management and Policy, No. 10, Xitoutiao, Youanmen Wai, Fengtai District, Beijing, 100069, People's Republic of China.
Junli Zhu *School of Public Health, Capital Medical University & Research Center for Capital Health Management and Policy, No. 10, Xitoutiao, Youanmen Wai, Fengtai District, Beijing, 100069, People's Republic of China. smallying@126.com.
Yao DongSchool of Public Health, Capital Medical University & Research Center for Capital Health Management and Policy, No. 10, Xitoutiao, Youanmen Wai, Fengtai District, Beijing, 100069, People's Republic of China.
Yun ChenBeijing Key Laboratory of Mental Disorders, National Clinical Research Center for Mental Disorders & National Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, People's Republic of China.
Chen ChenCapital Medical University Affiliated Anzhen Hospital, Beijing, People's Republic of China.
Wei LuBeijing Jishuitan Hospital, Capital Medical University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with severe mental disorders (SMD) face a heavy financial burden, and somatic comorbidity is one of the factors that cannot be ignored. The purpose of this study is to understand the current status of somatic comorbidity in patients and to explore the relationship between medical expenses and different somatic disease comorbidities.

methodThe group obtained medical data of 4940 patients in 2019 through a follow-up survey. Descriptive statistics were used to analyze the distribution of patient co-morbidities, and CLAD was used to analyze the impact of various factors on patient expenses.

resultsThe most common comorbidity was circulatory disorders (36.6%), followed by respiratory disorders (32.3%), digestive disorders (30.6%) and endocrine, nutritional or metabolic disorders (29.8%). As the types of somatic comorbidity increase, the expenses will also increase. In terms of comorbidity types, a total of 9 ICD-11 chapter group diseases will lead to increased expenses, while 5 chapter group diseases have no statistically significant impact on expenses.

conclusionsThis study found that comorbidities are widespread in patients with SMD, and most of them lead to a significant increase in patients' medical expenses. Therefore, the treatment of patients with severe mental disorders should take into account the needs of the prevention, management and treatment of the comorbidity of the population, reduce the occurrence and development of patients' somatic comorbidity, and thus reduce the burden of patients' medical expenses.

Indexed as

Health Care CostsMental DisordersAdolescentAdultAgedBeijingCardiovascular DiseasesComorbidityCross-Sectional StudiesFemaleHumansMaleMiddle AgedYoung AdultCommunity mental healthComorbidity impactHealthcare costsHealth service researchSevere mental disorders

Identifiers

PMID41310537
PMCPMC12659471

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.